OOIR: Observatory of International Research

Papers

(The TQCC of Immunology and Allergy Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Allergic Rhinitis in Children and Adolescents	39
Defining Common Variable Immunodeficiency Disorders in 2020	38
Anaphylaxis and Mast Cell Disorders	28
Global Climate Change and Pollen Aeroallergens	27
Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis	24
Racial/Ethnic Differences in Food Allergy	23
The Role of Extreme Weather and Climate-Related Events on Asthma Outcomes	22
Dietary Management of Food Allergy	21
Innate Immunity	21
IKAROS Family Zinc Finger 1–Associated Diseases in Primary Immunodeficiency Patients	19
Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders	18
Genetics of Food Allergy	17
Chronic Lung Disease in Primary Antibody Deficiency	16
Air Pollution Effects in Allergies and Asthma	14
Targeting Mast Cells with Biologics	14
Climate Change and Pollen Allergy in India and South Asia	14
Biologics for Atopic Dermatitis	13
The Role of Smoking in Asthma and Chronic Obstructive Pulmonary Disease Overlap	12
Biologics and Novel Therapies for Food Allergy	12
The Impact of Climate Change on Pollen Season and Allergic Sensitization to Pollens	12
Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions	12
Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation	11
Climate Change, Air Pollution, and Biodiversity in Asia Pacific and Impact on Respiratory Allergies	11
The Infant Microbiome and Its Impact on Development of Food Allergy	10
Contact Urticaria	10

Anaphylaxis	9
Asplenia and Hyposplenism	9
The Who, What, Where, When, Why, and How of Drug Desensitization	9
Allergy to Radiocontrast Dye	9
Psychosocial Aspects of Food Allergy	9
Biologics for the Treatments of Allergic Conditions	9
Perioperative Anaphylaxis	8
New Insights and Treatments in Atopic Dermatitis	8
Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E–Mediated Drug Hypersensitivity	8
Recognizing Drug Hypersensitivity in Pigmented Skin	8
Innate Immune Regulation of Dermatitis	8
Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases	8
Precision Therapy for the Treatment of Primary Immunodysregulatory Diseases	8
Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity	8
Hemophagocytic Lymphohistiocytosis	8
Insect Migration and Changes in Venom Allergy due to Climate Change	7
Anaphylaxis	7
Phenotypes of Asthma–Chronic Obstructive Pulmonary Disease Overlap	7
Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy	7
Climate Change Factors and the Aerobiology Effect	7
The Unmet Needs of Patients with Food Allergies	7
Anaphylaxis in Children and Adolescents	7
Pharmacogenomics of Drug Hypersensitivity	7
Effect of Climate Change on Allergenic Airborne Pollen in Japan	7
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity	7
Anaphylaxis to Excipients in Current Clinical Practice	7
Anaphylaxis	6
Pathophysiology of Immunologic and Nonimmunologic Systemic Reactions Including Anaphylaxis	6
Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis	6
Diagnosis and Management of Food Allergy	6
Allergenic Pollen Season Variations in the Past Two Decades Under Changing Climate in the United States	6
The Importance of Primary Immune Deficiency Registries	6
Pediatric Drug Allergy	6
Management of Anaphylaxis	6
Vaccines in Patients with Primary Immune Deficiency	6
Pediatric Allergic Contact Dermatitis	6
Sarcoidosis	5
Drug Hypersensitivity Reactions	5
Climate Change and Extreme Weather Events in Australia	5
The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021	5
Newborn Screening for Severe Combined Immunodeficiency	5
Asthma-Chronic Obstructive Pulmonary Disease Overlap	5
Eosinophilic Esophagitis	5
Anaphylaxis to Stinging Insect Venom	5
Mimics of Dermatitis	5
Viral Infections and Wheezing in Preschool Children	5
Eosinophilic Lung Diseases	5
Biologics for the Treatment of Food Allergies	5
Biologic Agents for the Treatment of Anaphylaxis	5
Tackling Food Allergy in Infancy	4

Forecast for Pollen Allergy	4
Current and Potential Biologic Drugs for the Treatment of Chronic Urticaria	4
Chronic Management of Asthma During Pregnancy	4
Drug and Venom Allergy in Mastocytosis	4
World Health Organization Classification and Diagnosis of Mastocytosis	4
Post-COVID Interstitial Lung Disease—The Tip of the Iceberg	4
Nuts and Bolts of Subcutaneous Therapy	4
Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models	4
Recognition and Management of Food Allergy and Anaphylaxis in the School and Community Setting	4
Occupational Interstitial Lung Diseases	4
Ozone in the Development of Pediatric Asthma and Atopic Disease	4
Hereditary Angioedema	4
A Risk-Based Approach to Penicillin Allergy	4